Churchill P, McIntyre J O, Vidal J C, Fleischer S
Arch Biochem Biophys. 1983 Jul 15;224(2):659-70. doi: 10.1016/0003-9861(83)90253-9.
Liver mitochondria from rats made diabetic with streptozotocin have a reduced level of D-beta-hydroxybutyrate dehydrogenase (BDH) activity and decreased ratios of oleic/stearic and arachidonic/linoleic acids in the phospholipids of the mitochondrial membrane. This altered activity and lipid environment result from insulin deprivation since maintenance of the diabetic rats on insulin leads to normal characteristics (J.C. Vidal, J.O. McIntyre, P.F. Churchill, and S. Fleischer (1983) Arch. Biochem, Biophys. 224, 643-658). In the present study, the basis for the reduced enzymatic activity of this lipid-requiring enzyme was analyzed using three approaches: (i) Purified D-beta-hydroxybutyrate, dehydrogenase was inserted into membranes from mitochondria, submitochondrial vesicles, and mitochondrial lipids extracted therefrom. The activation was the same and optimal irrespective of whether the preparations were derived from normal or diabetic rat liver. Therefore, the decreased activity does not appear to be referable to an altered lipid composition. (ii) BDH activity can be released from the mitochondria by phospholipase A2 digestion. The released activity was proportional to the endogenous activity in the submitochondrial vesicles from normal and diabetic membranes. (iii) The BDH activity in submitochondrial vesicles was titrated by inhibition with specific antiserum. Less enzyme was found in mitochondria from diabetic rats as compared with those from normal animals. Hence, the lowered enzymatic activity is due to decreased enzyme in the mitochondrial inner membrane and not to the modified lipid environment.
用链脲佐菌素诱导产生糖尿病的大鼠的肝脏线粒体,其D-β-羟丁酸脱氢酶(BDH)活性水平降低,线粒体膜磷脂中油酸/硬脂酸以及花生四烯酸/亚油酸的比例也降低。这种活性和脂质环境的改变是由于胰岛素缺乏所致,因为给糖尿病大鼠持续注射胰岛素会使其恢复正常特征(J.C. 维达尔、J.O. 麦金太尔、P.F. 丘吉尔和S. 弗莱舍(1983年)《生物化学与生物物理学文献》224卷,643 - 658页)。在本研究中,使用三种方法分析了这种对脂质有需求的酶活性降低的原因:(i)将纯化的D-β-羟丁酸脱氢酶插入来自线粒体、亚线粒体小泡以及从中提取的线粒体脂质的膜中。无论这些制剂来源于正常大鼠肝脏还是糖尿病大鼠肝脏,其激活情况相同且都是最佳的。因此,活性降低似乎并非归因于脂质组成的改变。(ii)BDH活性可通过磷脂酶A2消化从线粒体中释放出来。释放出的活性与正常和糖尿病膜的亚线粒体小泡中的内源性活性成正比。(iii)用特异性抗血清抑制来滴定亚线粒体小泡中的BDH活性。与正常动物的线粒体相比,糖尿病大鼠的线粒体中发现的酶较少。因此,酶活性降低是由于线粒体内膜中酶的减少,而非脂质环境的改变。